We isolated the virus-specific RNA species from Uukuniemi virus-infected chicken embryo cells and fractionated them by sucrose gradient centrifugation. In addition to three RNA species cosedimenting with the three viral RNA segments L (29S), M (23S), and S (17S), a fourth major RNA species, sedimenting at about 12S (S2), was found early in the infection. Annealing experiments indicated that the cytoplasmic L and M RNA species consisted of both plus and minus strands, with the plus strands in slight excess. Most of the Si RNA was of negative polarity, whereas S2 was of positive polarity. The S2 RNA specifically annealed to the virion S RNA segment, indicating that it is transcribed from this segment. In vitro translation of the individual RNA species in micrococcal nuclease-treated cell-free reticulocyte extracts showed that an mRNA cosedimenting with the virion M RNA directed the synthesis of a virus-specific 110,000-dalton polypeptide (p110). This polypeptide could be immunoprecipitated with antiserum prepared against purified virions. When translation was carried out in the presence of dog pancreas microsomes, pllO was absent. Instead, an immunoprecipitable polypeptide band, with a molecular weight of about 70,000 and migrating between the virion surface glycoproteins Gl and G2, was observed. It is thus likely that the glycoproteins are synthesized as a precursor (p110), which during translation is cleaved roughly in the middle to yield Gl and G2. The 12S RNA species directed the synthesis of the nucleocapsid protein and a novel polypeptide with an apparent molecular weight of about 30,000. The latter was not precipitated with antivirion serum and was absent from lysates programmed with the corresponding RNA fraction from a mock-infected extract. Since, in addition, it was not found in purified virions and was present in the cytoplasm of infected cells but not in uninfected cells, it probably represents a nonstructural polypeptide.
We isolated the virus-specific RNA species from Uukuniemi virus-infected chicken embryo cells and fractionated them by sucrose gradient centrifugation. In addition to three RNA species cosedimenting with the three viral RNA segments L (29S), M (23S), and S (17S), a fourth major RNA species, sedimenting at about 12S (S2), was found early in the infection. Annealing experiments indicated that the cytoplasmic L and M RNA species consisted of both plus and minus strands, with the plus strands in slight excess. Most of the Si RNA was of negative polarity, whereas S2 was of positive polarity. The S2 RNA specifically annealed to the virion S RNA segment, indicating that it is transcribed from this segment. In vitro translation of the individual RNA species in micrococcal nuclease-treated cell-free reticulocyte extracts showed that an mRNA cosedimenting with the virion M RNA directed the synthesis of a virus-specific 110,000-dalton polypeptide (p110). This polypeptide could be immunoprecipitated with antiserum prepared against purified virions. When translation was carried out in the presence of dog pancreas microsomes, pllO was absent. Instead, an immunoprecipitable polypeptide band, with a molecular weight of about 70,000 and migrating between the virion surface glycoproteins Gl and G2, was observed. It is thus likely that the glycoproteins are synthesized as a precursor (p110), which during translation is cleaved roughly in the middle to yield Gl and G2. The 12S RNA species directed the synthesis of the nucleocapsid protein and a novel polypeptide with an apparent molecular weight of about 30,000. The latter was not precipitated with antivirion serum and was absent from lysates programmed with the corresponding RNA fraction from a mock-infected extract. Since, in addition, it was not found in purified virions and was present in the cytoplasm of infected cells but not in uninfected cells, it probably represents a nonstructural polypeptide.
The Bunyaviridae family comprises a large and heterogeneous group of arthropod-borne tiruses (24) . All members so far characterized have certain structural features in common. Thus, they all contain a segmented singlestranded RNA genome; regularly, three species of RNA (L, M, and S) with a negative polarity have been found in purified virions (4, 5, 7, 17, 21, 25) . The size of the segments varies from one member to another (17) . Fingerprint analysis of 32P-labeled RNA segments have unambiguously shown that each segment contains a unique nucleotide sequence and thus must encode different polypeptides (7, 21) . Four structural proteins are found in virions (16, 17) . The largest, L, is present in small amounts and is often difficult to detect in purified virions (16) . The two glycoproteins, Gl and G2, form the spikes on the viral surface, whereas the smallest, N, is the nucleocapsid protein (16, 23) . Again, the size of the polypeptides varies from one virus to another (17) .
On the basis of genetic recombination (reassortment of RNA segments) between temperature-sensitive mutants of different viruses within the California encephalitis virus complex, it has been concluded that the M RNA contains the information for the two glycoproteins (11) . In vitro translation of snowshoe hare virus-specific RNA isolated from infected cells has indicated that the S RNA segment encodes the nucleocapsid (N) protein (6, 10) . By exclusion it is therefore likely that the L RNA encodes the L protein.
Uukuniemi viruses form a distinct serological group within the Bunyaviridae family (24) . The prototype of the group, Uukuniemi virus, has been the subject of many detailed molecular analyses. The virion contains three RNA seg- M (molecular weight, 1.1 ± 0.2 x 106), and S (molecular weight, 0.5 ± 0.1 x 106), which by RNA fingerprinting have been shown to contain unique nucleotide sequences (21) . As is the case in other bunyaviruses, four structural proteins have been recognized: L (molecular weight, 180,000 to 200,000) (Pettersson, unpublished data), Gl (molecular weight, -75,000), G2 (molecular weight, -65,000), and N (molecular weight, 25,000) (23, 28) . It is therefore clear that one of the RNA segments must encode at least two polypeptides. So far, it has not been known which RNA segment encodes the different proteins. To study this, we have isolated, fractionated, and translated in vitro the virus-specific RNAs from infected cells and found that an mRNA species of the same size as the virion M RNA codes for a precursor to the two glycoproteins and that a 12S mRNA species, which is transcribed from the virion S segment, codes for the N protein and a novel nonstructural (NS) polypeptide.
MATERIALS AND METHODS
Preparation of [36Slmethionine-labeled cytoplasmic extracts. The origin and cultivation of chicken embryo cells as well as preparation of stock virus from the prototype strain S23 of Uukuniemi virus have been described previously (22) . Virus was labeled with [3S]methionine and purified by sucrose gradient centrifugation as described previously (22, 28) .
Secondary cultures of chicken embryo cells grown on 20-cm2 petri dishes as monolayers were infected with Uukuniemi virus at a multiplicity of about 10 PFU per cell. After a 60-min adsorption period at 37°C the unadsorbed virus was discarded, and the cells were washed once with Hanks salt solution and then maintained in Eagle minimum essential medium supplemented with 0.2% bovine serum albumin. At different times after infection, methionine-free minimum essential medium was added 1 h before labeling of the cells.
[3S]methionine (Radiochemical Centre, Amersham, 750 Ci/mmol) in 2 ml of methionine-free minimum essential medium (100,Ci per dish) was added for 1 h. Mock-infected cells were treated and labeled similarly but the virus inoculum was omitted.
After labeling, the cells were washed twice with phosphate-buffered saline, scraped off the plate, and concentrated by centrifugation at 1,200 rpm for 10 min. The cells were suspended in 0.5 ml of RSB-Na buffer (10 mM NaCl, 1.5 mM MgCl2, 10 mM Trishydrochloride [pH 7.4] ) and allowed to swell for 15 min at 00C. The cells were then disrupted by 30 strokes in a Dounce homogenizer, and the nuclei were removed by centrifugation for 5 min at 1,500 rpm. Triton X-100 (1% final) was added to the supernatant, and the nuclei were washed once with RSB-Na containing 1% Triton X-100. The nuclear wash and the supernatant were pooled and used for immunoprecipitation and analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (13 Preparation of rabbit reticulocyte lysate and translation in vitro. Reticulocyte lysate was prepared from the blood of anemic rabbits as described by Villa-Komaroff et al. (27) and made mRNA dependent by treatment with micrococcal nuclease by the method of Pelham and Jackson (18) . A standard assay mixture (25 ul) contained 10 pl of lysate, 0.5 mM spermidine (Sigma Chemical Co.), 25 ,IM amino acids (omitting methionine) (BDH), 2 mM dithiothreitol (Calbiochem), 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.6; Sigma), 16 .ug of hemin (Eastman Organic Chemicals) per ml, 8 mM creatine phosphate, 140 Lg of creatine phosphokinase (Sigma) per ml, 30 Persson et al. (19) .
The procedure included incubation of diluted cell extract or in vitro reaction mixtures with normal rabbit serum (1 h at 200C and 1 h at 00C, respectively) followed by mixing of the bacteria with the samples. Bacteria were collected by centrifugation, and the supernatant was used for immunoprecipitation with either immune or preimmune serum (10 pl per assay).
Incubations were as above, and the precipitates were washed twice with phosphate-buffered saline and once with water before adding the gel sample mixture and heating for 2 min at 1000C.
Antiserum against purified Uukuniemi virus was prepared in rabbits by injecting 100 jig of Triton X-100-disrupted virus in Freund complete adjuvant. Three booster injections of 70 ug of virus each were given subcutaneously at 3-week intervals. Rabbits were bled before each injection, and the sera were checked for the presence of antibodies against the major viral structural proteins. Protein samples were analyzed in SDS-polyacrylamide slab gels by the method of Laemmli (13) the N protein, which started to appear at about 6 h p.i. (Fig. 1 , lane e) and was synthesized throughout the period studied (to 37 h p.i.). Neither the Gl and G2 proteins, which did not separate well in this run (Fig. 1, lane o) , nor the L protein can be seen at anymtie. A polypeptide, migrating ssghtly slower than the N pSrDotein and absent from mock-infected cels (Fig. 1, lanes a  and n) can be clearly seen (Fig. 1, lane m, arrow) . This protein band is visible from about 8 h p.i. (Fig. 1, lanes f to in) .
To reveal the glycoproteins, the viral structural proteins were immunoprecipitated from the extracts with antiserum prepared against whole virions (Fig. 2) . Both the Gl and G2 (first visible from about 14 h p.i. with this method) (Fig. 2, lane e) [20] ). Cytoplasmic extracts were prepared, and the RNA was phenol extracted and analyzed by sucrose gradient centrifugation (Fig.  3) . Four corresponding fractions from mock-infected gradients were pooled individually and are herein referred to as pools I, II, III, and IV. After ethanol precipitation, the RNAs were used for in vitro translation assays in reticulocyte lysates (Fig. 4A through D) .
Each of the four RNA pools directed the synthesis of a number of polypeptides, most of which were translated from RNA isolated from both infected and mock-infected extracts. Since the L protein (molecular weight, 180,000 to 200,000) is too large to be encoded by the M and S segments, it has to be a product of the L segment. Although polypeptides larger than 200,000 daltons were synthesized from RNAs in pool I (Fig. 4A) , no polypeptide identifiable as the L protein was detected; there was no difference between the infected and mock-infected extracts (Fig. 4A, lanes a and b) , and no polypeptides were immunoprecipitated with antivirion serum (Fig. 4A, lane c) .
From infected pool II (Fig. 4B ) a polypeptide with an apparent molecular weight of about 110,000 (relative to several molecular weight markers) was synthesized (Fig. 4B, lane b, arrow) . This polypeptide was absent in the lysate programmed with the mock-infected pool II (Fig. 4B, lane a) and was selectively precipitated with antivirion serum (Fig. 4B, lane c, arrow) . We designated this polypeptide p110. (Fig. 40) yielded similar polypeptide patterns. The only difference was a polypeptide made from the'RNA of infected pool III that comigrated with the virion N protein (Fig. 40,   lane b) . This product, which was precipitated with antivirion serum (Fig. 40, lane c) , is probably translated from a contaminating mRNA species present in pool IV (see below).
A major in vitro product that comigrated with the virion N protein was synthesized from RNA in the infected pool IV (Fig. 4D, lane b) . It was readily precipitated with antivirion serum Fig.  4D , lane c) and was absent from the lysate programmed with RNA from the corresponding mock-infected pool IV (Fig. 4D, lane a) . Roughly half of the incorporated radioactivity could be recovered in this product. In addition, a product migrating slghtly slower than the N protein (molecular weight, -30,000) was synthesized from the infected pool IV (Fig. 4D, lane b, arrow) . This product was absent from mock-infected pool IV (Fig. 4D, lane a) , did not comigrate with any of the structural polypeptides, and was not precipitated with virion antiserum (Fig. 4D, lane c) . We therefore called it NS (nonstructural).
Processing of p1lO by dog pancreas microsomes in vitro. None of the RNA pools directed the synthesis of polypeptides of the size of Gl or G2. Instead, a 110,000-dalton polypeptide (p110) was made from the infected pool II RNA (M RNA fraction) (Fig. 4B, lanes b and c) . In the case of snowshoe hare virus, a serologically unrelated bunyavirus, the M RNA has been shown to encode the two glycoproteins Gl (molecular weight, 115,000) and G2 (molecular weight, 38,000) (11) . It was therefore conceivable that the Uukuniemi virus glycoproteins also are encoded by an mRNA with the size of M RNA and that the glycoproteins in fact are synthesized as a precursor, which posttranslationally is cleaved roughly in the middle. To test this possibility, we translated the pool II RNA in the presence and absence of dog pancreas microsomes to see whether pllO would be processed. Microsomal membranes, when added to in vitro translation lysates have been shown to facilitate the glycosylation and processing of membrane proteins ofseveral enveoped RNA viruses during the translation event (8, 9, 26, 29) . pllO was present in the initial translation product mixture (Fig. 5, lane c) , and was selectively immunoprecipitated with antiserum (Fig. 5, lane d, arrow) . In the presence of membranes, pllO quantitatively disappeared, and a new immunoprecipitable band appeared that migrated between the Gl and G2 virion markers (Fig. 5, lane e, arrow) . Thus, addition of membranes resulted in the cleavage of pllO roughly in the middle.
DISCUSSION
In this study, we have fractionated Uukuniemi virus-specific RNAs from infected cells and translated them in cell-free reticulocyte lysates. Two of the four RNA species found in sucrose gradients directed the synthesis of virus-specific polypeptides, namely, an mRNA species cosedimenting with the virion M RNA (23S), which gave rise to a novel 110,000-dalton protein (p110), and a small 12S mRNA species, called S2, which directed the synthesis of the virion N protein and a 30,000-dalton NS None of the RNA pools from infected cells directed the synthesis of the large L protein (180,000 to 200,000 daltons) despite the fact that the lysates were able to synthesize host polypeptides larger than 200,000 daltons from the 29S RNA fraction. Based on size, the only RNA segment large enough to encode the L protein is the L RNA segment. Our inability to synthesize the L protein may be due to the presence of two small amounts of the L mRNA. The L protein is not detectable in infected cells and is present in virions in very small quantities (16; Pettersson, unpublished data). Another possibility is that the mRNA and virion RNA may have formed hybrids during the isolation procedure thereby inactivating the mRNA as a template for translation.
An mRNA species cosedimenting with the virion M RNA stimulated the synthesis of a novel virus-specific 110,000-dalton polypeptide. When translation was carried out in the presence of dog pancreas microsomes, the pllO was absent, and a new polypeptide band migrating between the Gl and G2 glycoproteins appeared instead. Both polypeptides were immunoprecipitated with antivirion serum and were absent from lysates incubated with corresponding RNA from mock-infected cells. Thus, they must be virus specific. We interpret the results to mean that the glycoproteins are synthesized as a 1 10,000-dalton precursor in the absence of membranes, whereas in the presence of membranes this precursor is cleaved roughly in the middle. The fact that the cleaved products migrated as one band between Gl and G2 could be due to incomplete glycosylation (especially lack ofsialic acid) with altered mobility as a consequence. In vitro posttranslational modifications by microsomal membranes have previously been shown to occur for four other enveloped RNA viruses. Vesicular stomatitis virus glycoprotein (G) is glycosylated in two discrete steps during translation of the G mRNA in vitro in the presence of microsomes (26) . Under similar conditions, the Semliki Forest virus glycoprotein precursor, p97, is nascently cleaved to El (52,000 daltons) and p62 (the precursor of E3 and E2), which similarly are glycosylated and inserted into the endoplasmic membrane (9) . The glycoproteins of Sindbis virus, which is closely related to Semliki Forest virus, are synthesized in the same way (29) . In the case of influenza virus, the hemagglutinin (HA) is synthesized as an unglycosylated 63,000-dalton precursor in the absence of membranes and is converted to a glycosylated 75,000-dalton polypeptide in the presence of membranes (8) .
In contrast to what appears to be the case with Uukuniemi virus glycoproteins, the influenza HA precursor is not cleaved to the final products HA, and HA2 during the translation process.
Instead, the cleavage takes place at the plasma membrane during the final maturation stage (12) . Our results regarding the role of microsomal membranes in the modification of Uukuniemi virus glycoproteins have to be considered preliminary. More detailed analyses with methods described for the above viruses have to be done to elucidate these complex events.
The coding capacity of the M RNA has been estimated to be about 110,000 to 120,000 daltons of protein (21) . The size of the precursor (p110) therefore suggests that the M segment is large enough to encode the two glycoproteins and that the genetic capacity of this segment is efficiently used. Our results agree with previous observations by Gentsch and Bishop (11) who showed by genetic recombination between temperaturesensitive mutants of two bunyaviruses that the M RNA segment of snowshoe hare virus encodes both glycoproteins.
Uukuniemi virus N protein was translated from an mRNA species smaller than any of the virion RNA segments (12S). The same RNA fraction also directed the synthesis of a 30,000-dalton polypeptide, which was not found in virions, was not precipitated by virion antiserum, and was absent from lysates programmed with the corresponding size-fraction RNA from mockinfected extracts. In addition, a polypeptide with similar mobility was seen in extracts from pulselabeled infected cells from about 8 h p.i. This protein, which we call NS, may therefore represent a nonstructural polypeptide. The preliminary hybridization experiments suggest that the S2 RNA(s) is transcribed from the virion S RNA. The fact that in the case of snowshoe hare virus the N protein is translated in vitro from an mRNA derived from the S RNA (10) supports this conclusion. No evidence for a similar NS protein was, however, found with snowshoe hare virus. The Uukuniemi virus S RNA segment has been estimated to have a molecular weight of about 0.5 ± 0.1 x 106 (21) and therefore the genetic capacity to encode a protein of roughly 50,000 daltons. The estimated combined size of N and NS is about 55,000 daltons. Thus, the coding capacity of the S RNA would be fully used. We do not know yet whether the N and the NS proteins are translated from two different mRNA's of roughly the same size, or from the same 12S mRNA. The situation with the S RNA segment of Uukuniemi virus resembles that of the eighth segment of influenza virus. It has recently been shown (15) that the smallest (eighth) RNA segment of influenza virus is transcribed into two separate mRNA's, each coding for one of the NS polypeptides NS1 and NS2. The mRNA for the NS2 (about 340 nucleotides) is identical to the 3' portion of the NS1 mRNA (about 860 nucleotides), and the proteins are translated from the mRNA's partly in different reading frames (15) . A similar situation could also exist in the case of Uukuniemi virus S RNA segment. Another possibility would be that the Uukuniemi virus NS protein is a precursor of the N protein. This is highly unlikely, since the NS is not precipitated with antivirion serum, which efficiently precipitates the N protein.
Lack of sufficient material has so far prevented comparison of the two proteins by tryptic peptide analysis or partial proteolysis.
